OMCL logo

Omnicell, Inc. Stock Price

NasdaqGS:OMCL Community·US$1.9b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 4 Fair Values set on narratives written by author

OMCL Share Price Performance

US$41.25
3.52 (9.33%)
US$57.43
Fair Value
US$41.25
3.52 (9.33%)
28.2% undervalued intrinsic discount
US$57.43
Fair Value
Price US$41.25
AnalystConsensusTarget US$57.43
AnalystLowTarget US$50.00
AnalystHighTarget US$63.00

OMCL Community Narratives

AnalystConsensusTarget·
Fair Value US$57.43 28.2% undervalued intrinsic discount

OmniSphere Adoption Will Simplify Healthcare Medication Management

0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
AnalystLowTarget·
Fair Value US$50 17.5% undervalued intrinsic discount

Government Cost Containment And Cybersecurity Burdens Will Impair Margins

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystHighTarget·
Fair Value US$63 34.5% undervalued intrinsic discount

Aging Population And Digital Transformation Will Drive Medication Automation

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US$63
34.5% undervalued intrinsic discount
Revenue
6.33% p.a.
Profit Margin
5.66%
Future PE
38.44x
Price in 2029
US$77.68
US$50
17.5% undervalued intrinsic discount
Revenue
3.97% p.a.
Profit Margin
5.98%
Future PE
30.95x
Price in 2029
US$61.69

Trending Discussion

Updated Narratives

OMCL logo

OMCL: Cabinet Refresh Cycle Will Support Future Medication Management Upside

Fair Value: US$57.43 28.2% undervalued intrinsic discount
3 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
OMCL logo

OMCL: Cabinet Replacement Cycle Could Drive Upside In Concentrated Market

Fair Value: US$63 34.5% undervalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
OMCL logo

OMCL: Cabinet Replacement Cycle Will Shape Future Risk Reward Balance

Fair Value: US$50 17.5% undervalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet and good value.

2 Risks
3 Rewards

Omnicell, Inc. Key Details

US$1.2b

Revenue

US$676.8m

Cost of Revenue

US$508.0m

Gross Profit

US$506.0m

Other Expenses

US$2.1m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
0.045
42.88%
0.17%
13.6%
View Full Analysis

About OMCL

Founded
1992
Employees
3580
CEO
Randall Lipps
WebsiteView website
www.omnicell.com

Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Recent OMCL News & Updates

Recent updates

No updates